8IS1.F - Invictus MD Strategies Corp.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
1.10
+0.07 (+6.80%)
As of 4:49PM CEST. Market open.
Stock chart is not supported by your current browser
Previous Close1.03
Open1.07
Bid1.11 x 850000
Ask1.21 x 500000
Day's Range1.07 - 1.16
52 Week Range0.76 - 1.84
Volume3,747
Avg. Volume1,012
Market Cap119.549M
Beta (3Y Monthly)24.29
PE Ratio (TTM)N/A
EPS (TTM)-0.16
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group4 days ago

    GTEC Holdings Announces First Retail Cannabis Stores Scheduled to Be Operational in 2018

    KELOWNA, BC , Oct. 11, 2018 /CNW/ - GTEC Holdings Ltd. (GTEC.V) (GGTTF) ("GTEC" or the "Company") is pleased to provide the following updates on its retail operations. Cannabis Cowboy has currently received 10 development permits from their respective municipalities in Alberta , which include locations in Calgary , Red Deer , and Lethbridge . Cannabis Cowboy expects to have 11 retail locations opened and operational in Q4 2018, with an additional 14 locations to be opened in Q1 2019.

  • GlobeNewswire19 days ago

    Invictus Announces $20 Million Equity Financing

    FRA: 8IS1) announces that it has entered into an agreement with PI Financial Corp. and GMP Securities L.P. as co-lead underwriters on behalf of a syndicate of underwriters (the "Underwriters"), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis pursuant to a short form prospectus, 10,000,000 units (the "Units") of the Company at a price of C$2.00 per Unit (the "Offering Price") for gross proceeds of C$20,000,000 (the "Underwritten Offering"). In connection with the Offering, Eventus Capital Corp. has been appointed as a special advisor to the Company.

  • CNW Group21 days ago

    Invictus Provides Update on German Partnership and EU-GMP Certification

    VANCOUVER , Sept. 24, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (GENE.V) (IVITF) (8IS1.F) is pleased to provide an update on its progress towards European Union Good Manufacturing Practices ("EU-GMP") certification. Invictus' wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), has designed and is currently building its Phase 3 and 4 purpose-built cultivation facilities to be EU-GMP compliant. EU-GMP standards are the most stringent regulations in the world and our team at Acreage Pharms are working together with professional consultants in both Canada and Germany to meet these standards.

  • CNW Grouplast month

    Invictus' Acreage Pharms to Become a Registered Cannabis Supplier in Saskatchewan

    VANCOUVER , Sept. 11, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (GENE.V) (IVITF) (8IS1.F) is pleased to announce that its wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), has been granted conditional approval to become a registered supplier with the Saskatchewan Liquor and Gaming Authority ("SLGA") once legislation is implemented on October 17, 2018 . In the interim, and subject to any federal restrictions, Acreage Pharms is eligible to supply product to authorized provincial wholesalers and retailers in advance of October 17 . "We are thrilled to become a registered supplier in Saskatchewan , our third provincial agreement behind British Columbia and Alberta ," said Dan Kriznic CEO and Chairman for Invictus.

  • Invictus' Acreage Pharms' Phase 2 is Now Complete
    CNW Group5 months ago

    Invictus' Acreage Pharms' Phase 2 is Now Complete

    FRA: 8IS1) is pleased to announce that the Acreage Pharms Ltd ("Acreage Pharms") 33,000 square foot, purpose built Phase 2 production facility is complete.  Land clearing and site preparation for its 80,000 square foot Phase 3 expansion project has commenced giving the licensed producer a total of 120,000 square feet of growing space by the end of 2018. Acreage Pharms is also working on plans to increase total capacity to 360,000 square feet in 2019.

  • Invictus' AB Laboratories and AB Ventures Reach Important Milestones
    CNW Group7 months ago

    Invictus' AB Laboratories and AB Ventures Reach Important Milestones

    Invictus' AB Laboratories and AB Ventures Reach Important Milestones

  • Invictus' AB Laboratories and AB Ventures Reach Important Milestones
    PR Newswire7 months ago

    Invictus' AB Laboratories and AB Ventures Reach Important Milestones

    FRA: 8IS1) AB Laboratories Inc. ("AB Labs") is pleased to announce the closing of the acquisition of the land and building (the "Property") next door for $5.2 million for its Phase 2 expansion.  The address of the Property has been consolidated with AB Labs existing address to allow the existing cultivation and sales license to extend to the Property.  The milestone allows AB Labs to continue moving ahead with its aggressive cannabis production capacity, as Canada marches towards full legalization during 2018. "Acquiring and consolidating these facilities at AB Labs has been of keen importance and we are delighted to formally secure the merging of the facilities and to begin the next steps towards delivering AB Labs to full production," said Dan Kriznic, Chairman and CEO of Invictus.

  • Newsfile9 months ago

    IIROC Trade Resumption - Invictus MD Strategies Corp.

    Vancouver, British Columbia--(Newsfile Corp. - January 10, 2018) - Trading resumes in: Company: Invictus MD Strategies Corp. TSX-V Symbol: IMH ...

  • Newsfile9 months ago

    IIROC Trade Halt - Invictus MD Strategies Corp.

    Vancouver, British Columbia--(Newsfile Corp. - January 10, 2018) - The following issues have been halted by IIROC: Company:  Invictus MD Strategies Corp. TSX-V Symbol: IMH ...

  • Newsfile9 months ago

    IIROC Trade Halt - Invictus MD Strategies Corp.

    Vancouver, British Columbia--(Newsfile Corp. - January 5, 2018) - The following issues have been halted by IIROC: Company:  Invictus MD Strategies Corp. TSX-V Symbol: IMH ...

  • PR Newswire11 months ago

    Invictus MD Strengthens Management Team With Appointment of New CFO

    FRA: 8IS1), is pleased to announce the appointment of Dylan Easterbrook as Chief Financial Officer. Mr. Easterbrook is a seasoned accounting and financial professional, who most recently was controller of a publicly traded global fibre optic connectivity solution provider.  Prior to that role he was with Ernst & Young, one of the largest professional services firms in the world and one of the Big Four accounting firms, where he led audit engagements for both public and privately held companies from a variety of industries, including the emerging markets. Dylan is a Canadian Chartered Professional Accountant (CPA, CA), and also holds a Bachelor of Science in Life Sciences degree from the University of British Columbia.

  • CNW Group11 months ago

    Invictus MD Strengthens Management Team With Appointment of New CFO

    Invictus MD Strengthens Management Team With Appointment of New CFO